Barclays »

Journey Med Corp shares owned by Barclays

Quarter-by-quarter ownership of Journey Med Corp (DERM) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Journey Med Corp

Tip: Access up to 7 years of quarterly data

All positions including Journey Med Corp held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Journey Med Corp by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $125k 18k 7.12
2025-06-30 $161k 22k 7.19

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Journey Med Corp

Tang Capital Management
Daniel D. Thurber
Opaleye Management
BlackRock
Vanguard Group
Summit Financial
Essex Investment Management
Geode Capital Management
Renaissance Technologies
Pale Fire Capital SE
American Financial Group
Pvg Asset Management
State Street Corporation
UBS Group
Sheets Smith Investment Management

View all funds holding Journey Med Corp